Latest News

Stock market news live updates: Stocks gain for a second day amid busy earnings lineup

S&P 500




Dow 30








Russell 2000




Crude Oil
















10-Yr Bond
















CMC Crypto 200




FTSE 100




Nikkei 225




U.S. equities charged forward for another day, extending a comeback that kicked off the week as earnings season sets into high gear.

The S&P 500 (^GSPC) surged 2.3% at the open, while the Dow Jones Industrial Average (^DJI) added 600 points, or 2%. The technology-heavy Nasdaq Composite (^IXIC) advanced 2.8%.

Sentiment got a boost Tuesday morning on third-quarter results from Goldman Sachs (GS) — Wall Street’s premier investment bank — which posted earnings that beat analyst estimates across the board despite challenging year-over-year comparisons. Shares rose more than 5% early into the session.

In an interview with CNBC, CEO David Solomon warned that there was a “good chance” the U.S. economy may enter a recession next year.

“That environment heading into 2023 is one that you’ve got to be cautious and prepared for,” he said.

Goldman Sachs is the last of the country’s six megabanks to unveil results. Despite better-than-feared figures from some names in financials that gave stocks a boost Monday, the banking industry has reported a year-over-year earnings decline of 13% for the third-quarter, driven primarily by increased provisions for loan losses to prepare for a possible recession, according to FactSet Research. Wall Street’s big banks are bellwethers of the U.S. economy and typically set the tone for the earnings season.

David Solomon, Chairman and CEO of Goldman Sachs, speaks at the 2022 Milken Institute Global Conference, in Beverly Hills, California, U.S., May 2, 2022. REUTERS/Mike Blake

The moves early Tuesday come after all three major averages rallied in the previous session, with the S&P 500, Dow, and Nasdaq notching gains of 2.7%, 1.9%, and 3.4%, respectively.

“As we continue to remind you, this kind of outsized move is not on its own historically indicative of either a healthy market or an investable low,” DataTrek Research Co-Founder Jessica Rabe said in a note.

The annual average number of days in which the S&P 500 gained more than 1% was 54 last year, while Monday’s bounce brings the year-to-date tally of such gains to 100 – an important threshold the benchmark index has only reached seven other years in the past six decades: during the Saudi oil embargo, the 2000 Dotcom Bubble, the 2008 Global Financial Crisis, and 2020’s pandemic crash.

With inflows to stocks near a record last week, investors have been ramping up bets that a market bottom is in. But many Wall Street strategists have argued that the optimism is premature, particularly as what’s expected to be a murky earnings season gets underway.

Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., October 14, 2022. REUTERS/Brendan McDermid

Bank of America’s global fund manager survey out Tuesday morning found that 91% of respondents said corporate earnings are unlikely to rise 10% or more in the next year, the highest share of investors in the survey’s history – a sign of further downside for forward earnings-per-share estimates for the S&P 500 index.

As such, BofA analysts deemed any indication that the end of the equity rout is near merely “tasty morsels for another bear rally,” adding that the institution projects a “big low” and subsequent “big rally” in the first half of 2023, when the Federal Reserve is expected to change course and start cutting rates.

This month’s survey “screams macro capitulation, investor capitulation, start of policy capitulation,” strategists led by Michael Hartnett wrote.

Tuesday will keep investors busy, with Wall Street assessing earnings from companies including Johnson & Johnson (JNJ), Hasbro (HAS), Netflix (NFLX), and United Airlines (UAL).

Alexandra Semenova is a reporter for Yahoo Finance. Follow her on Twitter @alexandraandnyc

Click here for the latest trending stock tickers of the Yahoo Finance platform

Click here for the latest stock market news and in-depth analysis, including events that move stocks

Read the latest financial and business news from Yahoo Finance

Download the Yahoo Finance app for Apple or Android

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube



BofA Survey ‘Screams’ Capitulation With Rally Set for Early 2023

(Bloomberg) — The sentiment on stocks and global growth among fund managers surveyed by Bank of America Corp. shows full capitulation, opening the way to an equities rally in 2023.Most Read from BloombergForecast for US Recession Within Year Hits 100% in Blow to BidenBlinken Says China Wants to Seize Taiwan on ‘Much Faster Timeline’Putin’s War Escalation Is Hastening Demographic Crash for RussiaS&P 500 Bounces Off Make-Or-Break Technical Level: Markets WrapThe Time to Buy the Dip Is Fast Approa


Dow jumps nearly 600 points as investors embrace earnings

U.S. stock index futures rose sharply early Tuesday as investors welcomed another round of corporate earnings reports and calmer conditions in bond markets bolstered appetite for risk.

Nancy Pelosi’s Stock Disclosure Reveals a Surprising Outcome

U.S. lawmakers have been under the microscope lately for trading stocks in companies where they or their staff members might have some inside knowledge. The rules for buying and selling stocks were strengthened for Congress in 2012 by the Stop Trading on Congressional Knowledge Act. Developing rules about Congress members trading stocks is an ongoing process.

American Airlines Will Pay Millions Over Huge Passenger Problem

Few travel nightmares can be worse than packing small to avoid paying for a checked bag and then, upon arriving at the airport, being told that the bag is too big and needs to be checked anyway. At the same time, a recent study from IdeaWorks found that the percentage of revenue airlines derive from baggage fees has been rising steadily — 3.7% in 2019, 3.9% in 2020 and 4.6% in 2021. In February 2021, five passengers who traveled with American Airlines filed a class action lawsuit that accused the airline of incorrectly charging them baggage fees that they were not required to pay.


Cathie Wood Doubles Down on These 2 Innovation Stocks

Not many hedge managers have ignited as much controversy as Cathie Wood. The founder of Ark Invest has built her brand on running against the crowd. From her early embrace of tech stocks to her outspoken political conservatism, Cathie Wood has always been something of a lightning rod. Wood is staking her reputation and fortune on a belief that new technologies, and especially the way that new technologies will interact with each other, are going to completely transform our world. In her view, se


J&J results beat estimates on cancer drug strength

The U.S. health conglomerate, which also sells medical devices and consumer health products such as Band Aid bandages and painkiller Tylenol, tightened its full-year adjusted profit forecast range. J&J has raised prices at its consumer health unit, which it expects to spin off in mid-to-late 2023, in response to surging inflation. On Tuesday, the company signaled that supply-chain pressures that pushed up costs at the unit were expected to ease next year.

Motley Fool

2 High-Yield Dividend Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague

When the curtain closes on 2022 in roughly two and a half months, Wall Street professionals and everyday investors are likely to look back on this year as one of the most trying on record. The first supercharged income stock that’s a screaming buy for value-oriented investors is pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA).

Motley Fool

Which Stock Is More Likely to 5X First: AbbVie or Tilray Brands?

A major pharmaceutical company like AbbVie (NYSE: ABBV) and a rising cannabis company like Tilray Brands (NASDAQ: TLRY) operate in different industries and have several other characteristics that make proper comparisons complicated. Tilray’s smaller size and strong position in a rapidly growing industry would suggest to some that its stock has great potential to 5x in value relatively quickly. In contrast, AbbVie’s got a large pipeline of potential new pharmaceuticals its developing.

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News